Gatta, L., Scarpignato, C., McCallum, R., Lombardo, L., Pimentel, M., D'Incà, R., . . . Cerda, E. (2017). Systematic review with meta‐analysis: Rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther.

Gatta, L., C. Scarpignato, R.W McCallum, L. Lombardo, M. Pimentel, R. D'Incà, A. Gasbarrini, A. De Stefano, and E. Cerda. "Systematic Review With Meta‐analysis: Rifaximin Is Effective and Safe for the Treatment of Small Intestine Bacterial Overgrowth." Aliment Pharmacol Ther 2017.

Gatta, L., et al. "Systematic Review With Meta‐analysis: Rifaximin Is Effective and Safe for the Treatment of Small Intestine Bacterial Overgrowth." Aliment Pharmacol Ther 2017.